Stay updated on Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.

Latest updates to the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays a 403 Forbidden error page with a minimal HTML header and a Home link. This indicates access is blocked rather than showing the study record content.SummaryDifference18%

- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded 2017 ( U.S. NIH Grant/Contract ) as a funding reference and updated the page revision to v3.6.6, replacing v3.6.5. These updates reflect administrative metadata and do not alter study design, eligibility criteria, or participant-facing information.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page shows Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a minor update to the page's revision metadata.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a new version of the page. This appears to be a minor metadata update rather than an alteration to substantive study information.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a minor patch to the page's underlying system. It does not add or modify visible content or features on the page.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, indicating a new page build. This does not change the displayed study information or user-facing functionality.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.